An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical technologies. That is the takeaway from a new report issued to the FDA, published this week in the open-access journal PLOS Medicine by Leo Celi of the Massachusetts Institute of Technology, and colleagues.

A new study led by Tulane University researchers reveals that generative AI tools, such as ChatGPT, can enhance employees' creativity — but only if they know how to think critically about their own work and utilize the tools effectively.

MIT researchers developed a computationally efficient method that could enable artists to design realistic simulations of elastic objects, like bouncy or squishy characters, for animated movies or video games.